Introduction
The JC virus (JCV) genome encodes six proteins: the oncogenic early proteins large T and small t antigens, the viral capsid proteins VP1, VP2, and VP3, and agnoprotein. Although the virion of wild-type JCV consists of VP1, VP2, and VP3, including the viral minichromosomes, recombinant VP1, which is the largest capsid protein, with a molecular weight of 40 kDa, can self-assemble into capsid-like structures that are similar to authentic JCV virions (Goldmann et al, 1999; Ou et al, 1999) . The 5 end of the JCV late region has the minimal open reading frame, which encodes a polypeptide of 71 amino acids, designated agnoprotein or leader protein (LP)-1 (Mertz et al, 1983) . The JCV agnoprotein shares 58% and 54% of homology with those of simian virus 40 (SV40) and BK virus (BKV), respectively. The agnoproteins of SV40 and BKV appear to be confined to the peri-nuclear region of the cytoplasm of virus-infected cells (Nomura et al, 1983; Rinaldo et al, 1998) . SV40 agnoprotein does not reside in the native virion and contributes to viral maturation, regulating transcription of the viral genome (Piatak et al, 1981; Alwine, 1982; Hay et al, 1982; Hay and Aloni, 1985) , translation of late viral proteins, processing of viral proteins, and assembly of virions (Stacy et al, 1989) . Recently, it has been reported that JCV agnoprotein functionally interacts with the viral early protein, large T antigen, and down-regulates viral gene expression and viral DNA replication (Safak et al, 2001) . These data suggest that the polyomavirus agnoproteins may play important roles in viral proliferation within host cells.
We have reported that agnoprotein is expressed in JCV-infected cells and is distributed in cytoplasmic processes (Okada et al, , 2002 . The intracellular distribution pattern of agnoprotein prompted us to investigate whether JCV agnoprotein interacts with cellular cytoskeletal proteins. In this study, we report that JCV agnoprotein is bound to the cellular cytoskeletal protein, tubulin.
Results

Intracellular localization of JCV agnoprotein
In order to analyze the intracellular localization of JCV agnoprotein, we have performed immunoblotting and immunocytochemical analysis of the JCV-producing cell line, JCI cells, which originated from the human neuroblastoma IMR-32 cells (Nukuzuma et al, 1995) , using anti-agnoprotein antibody (Okada et al, , 2002 . Immunoblotting with anti-agnoprotein antibody revealed that agnoprotein was exclusively detected in JCI cells at 8 kDa in size, whereas no signal was present in IMR-32 cells, which are the precursors of JCI cells (Figure 1a) . Immunofluorescence staining revealed that agnoprotein mainly localized in the cytoplasm in the JCI cells and was present in the long cytoplasmic processes as a punctate staining pattern (Figure 1b) . Double immunostaining analysis of JCV agnoprotein and the JCV capsid protein, VP1, with a laser scanning confocal microscope demonstrated that VP1 is predominantly detected in the nuclei, whereas agnoprotein localized in the perinuclear region and the cytoplasm with mesh-like staining pattern (Figure 1c) . No immunopositve signal was present in the IMR-32 cells (data not shown). These results suggested that JCV agnoprotein might interact with cytoskeletal proteins.
Detection of JCV agnoprotein-binding protein(s)
Because JCV agnoprotein is largely confined to the cytoplasm, and because proteins smaller than 60 kDa cannot overcome passive diffusion within the cytosol without interactions with associated molecule(s), we have assumed that agnoprotein-binding protein(s) play a role in its cytoplasmic localization. To investigate this, JCI cells were grown in the methioninefree Dulbecco's minimum essential medium (DMEM) supplemented with 10% dialyzed fetal bovine serum (FBS) containing 35 S-labeled methionine. The cellular lysates were incubated with anti-agnoprotein antibody, and the mixture was bound to protein A-Sepharose beads. After washing, bound proteins were eluted from the beads, and subjected to SDS-PAGE. Precipitated proteins were detected by autoradiography. The immunoprecipitation assay revealed five radioactive bands (approximately 52, 103, 112, 132, and 158 kDa), while nonspecific weak bands were also detected in lysates that were treated with rabbit immunoglobulin G (IgG) or beads only ( Figure 2 ). The molecular weight of tubulin is 54 kDa. This result, together with the cytoplasmic localization of agnoprotein, prompted us to examine the relationship between agnoprotein and the cytoskeletal protein tubulin.
Double immunostaining of agnoprotein and tubulin
To examine the localization of both agnoprotein and tubulin, agnoprotein was transiently expressed in the IMR-32 cells. Double immunostaining of JCV agnoprotein and tubulin revealed that exogenous JCV agnoprotein exclusively colocalized with tubulin in the cytoplasm and cytoplasmic processes (Figure 3 ). For use of anti-tubulin antibody, cells were fixed after detergent extraction performed under microtubulestabilizing conditions and processed for immunofluorescence. This method removes unassembled tubulin from the cell, so that the tubulin staining remaining in such cells can be attributable to the presence of microtubules (Gonzalez-Billault et al, 2001) . Our findings strongly suggested that agnoprotein colocalized with microtubules in IMR-32 cells.
Discussion
Agnoprotein is encoded by SV40, BKV, and JCV, but not by murine polyomavirus. BKV agnoprotein was reported to bind cellular proteins with molecular masses of approximately 50, 75, and 100 kDa (Rinaldo et al, 1998) . We have shown that JCV agnoprotein was distributed in the perinuclear region, the cytoplasm, and the long cytoplasmic processes as punctate staining in JCI cells. Agnoproteins of BKV and SV40 have similar intracellular localizations as JCV (Rinaldo et al, 1998; Nomura et al, 1983) . The expression of agnoprotein predominantly in the perinuclear and the cytoplasm led us to examine whether it interacts with cytoskeletal proteins. Immunocytochemical analysis suggested that JCV agnoprotein may interact with the cytoskeletal protein, tubulin, and modify its distribution and function in the cytoplasm of JCV-infected cells.
It has been recently reported that JCV agnoprotein interacts with viral large T antigen and downregulates viral gene expression and DNA replication in vitro (Safak et al, 2001 ). However, its cytoplasmic function has still not been fully investigated. Biochemical demonstration of the directed binding of the proteins and to define the domain within agnoprotein that are involved in the interaction with tubulin will be necessary for understanding the functional importance of the microtubule association (Endo et al, manuscript in preparation). The agnoprotein of JCV, BKV, and SV40 have a highly homologous amino acid sequence in the amino-terminal regions. Together with their similar intracellular distribution, the data suggest that the binding motif against tubulin may also be located in the amino-terminal region.
Materials and methods
Cell culture
Human neuroblastoma cell line IMR-32 (JCRB 9050) was purchased from the Health Science Research Resources Bank (Tokyo, Japan). The IMR-32-derived JCV-producing cell line, JCI, was established by Dr. Nukuzuma (Nukuzuma et al, 1995) . All cell lines were maintained in DMEM supplemented with 10% FBS, 2 mM L-glutamine (Sigma, St. Louis, MO), 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 50 units/ml penicillin and streptomycin (Gibco, Invitrogen, Carlsbad, CA) in humidified incubators with 5% CO 2 at 37
• C. Cells were grown on either collagen type-I-coated culture dishes (Iwaki, Tokyo, Immunoprecipitation of JCI cell lysates using antiagnoprotein antibody revealed five radioactive bands around 52, 103, 112, 132, and 158 kDa, whereas no band was detected in samples that were treated with rabbit IgG or beads only. As the molecular weight of tubulin is 54 kDa, tubulin was considered to be a potential candidate for agnoprotein-binding protein. 
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Japan) or on poly-L-lysine-coated slide glasses (Muto Pure Chemica, Tokyo, Japan).
Antibodies
Polyclonal antibody specific to the JCV agnoprotein was produced to a synthetic peptide consisting of 24 amino acids corresponding to the carboxylterminal amino acid sequence (48-71) of the protein deduced from agnogene of the Mad1 strain of JCV (Frisque et al, 1984) . New Zealand white rabbits were immunized with the peptide with an additional cysteine at its amino-terminus to facilitate the coupling to the carrier protein, keyhole limpet hemocyanin (KLH), as previously described . After immunization, the antibody was purified with an affinity column prepared by coupling the synthetic peptide to an N-hydroxysuccinimide (NHS)-activated Sepharose 4 FF (Amersham Pharmacia Biotech, Tokyo, Japan). Concentration of the purified antibody was determined from absorbance at 280 nm by using absorption coefficient of 1.34 (mg/ml)
• 1 (cm)
• 1 (Hurn and Chantler, 1980) . Biotinylated anti-agnoprotein antibody was prepared by using biotin (long arm) NHS ester (Vector Laboratories, Burlingame, CA) according to the manufacturer's instruction manual. Anti-VP1 antibody was generated by immunizing rabbits with virus-like particles prepared from recombinant VP1 expressed in Escherichia coli (Suzuki et al, 2001 ). Mouse monoclonal anti-μ-tubulin (B-5-1-2) and rabbit IgGs were obtained from Sigma. Horseradish peroxidaseconjugated goat F(ab ) 2 anti-mouse immunoglobulin (AMI4404) and horseradish peroxidase-conjugated goat F(ab ) 2 anti-rabbit IgG (ALI4404) were obtained from Biosource International (Camarillo, CA). Alexa Fluor 488-conjugated goat anti-rabbit IgG, Alexa Fluor 594-conjugated goat anti-rabbit IgG and goat anti-mouse IgG, and Alexa Fluor 488-conjugated streptavidine were obtained from Molecular Probes (Eugene, OR).
Immunocytochemistry JCI cells grown on poly-L-lysine coated slide glasses were fixed with methanol at • 30
• C for 3 min. For detection of tubulin, cells were treated with PHEM buffer [60 mM peperazine-N,N -bis(2-ethanesulfonic acid) (PIPES), 25 mM N-(2-hydroxyethyl)piperazine-N -(2-ethanesulfonic acid) (HEPES), 10 mM EGTA, 2 mM MgCl 2 , pH 6.9] containing 0.2% saponin, 10 μM paclitaxel, and 0.5% DMSO before methanol fixation (Gonzalez-Billault et al, 2001) . 
Metabolic labeling and immunoprecipitation
JCI cells (at 80% to 90% confluence) were labeled for 16 h with 0.02 mCi/ml of L-[
35 S]methionine (Amersham Biosciences, Piscataway, NJ) in 90% methionine-depeleted DMEM. After labeling, the cells were lysed in a lysis buffer [50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.05% NaN 3 , pH 7.4, containing protease inhibitors (1 mM phenylmethyl sulfonyl fluoride [PMSF], 1 μg/ml aprotinin, 2 μM leupeptin, 2 μM pepstatin, 0.5 mg/ ml Pefablock, 2 mM benzamidine HCl, 0.1 mM benzethonium Cl, 3 μg/ml trans-epoxysuccinyl-Lleucylamido-(4-guanidino)butane (E64), 20 μg/ml bestatin, pH 7.4) and phosphatase inhibitors (1 mM NaF, 1 mM Na 3 VO 4 )] for 30 min on ice. After centrifugation at 20,000 rpm at 4
• C for 20 min, the cell extract was subjected to immunoprecipitation with either purified anti-agnoprotein antibody or rabbit IgG. Immune complexes were recovered with a protein A-Sapharose 4FF, and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
SDS-PAGE and immunoblotting
The cell lysates were mixed with the SDS sample buffer followed by sonication, thereafter analysed by SDS-PAGE using 17% gel (Laemmli, 1970) . Proteins transferred onto a polyvinyldifluoride (PVDF) membrane (Haid and Suissa, 1983) was incubated in blocking buffer (5% [w/v] nonfat dry milk, 0.5% [v/v] Tween-20, PBS, pH 7.5) overnight, and incubated with anti-agnoprotein antibody (1:2000) for more than 6 h. After three washes with PBS containing 0.5% (v/v) Tween 20 (PBS-T) for 10 min, the membrane was incubated with horseradish peroxidaseconjugated second antibody (1:5000) for 2 h. The signal was detected with the ECL reaction, and visualized with the LAS-1000 plus system (Fujifilm, Tokyo, Japan).
Exogenous expression of agnoprotein in IMR-32 cells
Recombinant agnoprotien was expressed in IMR-32 cells with the pSFV1 eukaryotic expression system (Invitrogen) according to the method described in the S Endo et al manufacturer's instruction manual. Briefly, cDNA of agnogene containing the Kozak sequence and AUG translation initiation site was subcloned into the Bam HI site of the pSFV1 vector. After linearization with Spe I, recombinant agno mRNA was transcribed by
